Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Core EBITDA Growth

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -32.0135.7080.69186.95-48.93

What is the latest Core EBITDA Growth ratio of NATCO PHARMA ?

The latest Core EBITDA Growth ratio of NATCO PHARMA is -32.01 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-32.01
Mar202535.70
Mar202480.69
Mar2023186.95
Mar2022-48.93

How is Core EBITDA Growth of NATCO PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2026 -32.01
Negative
Mar2025 35.7
-55.76
Mar2024 80.69
-56.84
Mar2023 186.95
Positive
Mar2022 -48.93 -

Other Financial Ratios of NATCO PHARMA


Compare Core EBITDA Growth ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,397.8 Cr -0.7% -3.4% -3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,427.0 Cr 0.2% -4.1% 5.5% Stock Analytics
DIVIS LABORATORIES ₹239,982.0 Cr -3.1% -1.6% 47.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,196.0 Cr -1.2% -5% 29.4% Stock Analytics
CIPLA ₹107,746.0 Cr 2.3% -2% -13.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,894.0 Cr 2.2% 6.2% -2.5% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-0.7%

-3.4%

-3%

SENSEX

3.8%

-0.6%

-9.1%


You may also like the below Video Courses